Our latest paper in collaboration with Pfizer on the role of OCT2/MATE in creatinine clearance is accepted in JPET.
3rd October 2023 - 5 October, 2023
The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting brings world class content, bringing two tracks of learning to tackle the pressing challenges faced in the pre-clinical stages and in clinical development. This includes challenges faces with drug targets including wet AMD, dry AMD, DME, IRDs and more.
Share on social media:
Don't miss out on our latest innovations: follow us on Linkedin